Cita APA (7a ed.)

S, X., X, H., W, Y., W, S., X, Y., S, D., . . . X, L. (2021). Endoglin-Aptamer-Functionalized Liposome-Equipped PD-1-Silenced T Cells Enhance Antitumoral Immunotherapeutic Effects. Dove Medical Press.

Cita Chicago Style (17a ed.)

S, Xie, et al. Endoglin-Aptamer-Functionalized Liposome-Equipped PD-1-Silenced T Cells Enhance Antitumoral Immunotherapeutic Effects. Dove Medical Press, 2021.

Cita MLA (8a ed.)

S, Xie, et al. Endoglin-Aptamer-Functionalized Liposome-Equipped PD-1-Silenced T Cells Enhance Antitumoral Immunotherapeutic Effects. Dove Medical Press, 2021.